Pharmaceuticals

Global Toxicology Drug Screening Market Report 2026: Emerging Trends and Growth Scenarios

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the toxicology drug screening market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Toxicology Drug Screening Market from 2026 to 2030?

The toxicology drug screening market has shown substantial growth in recent years. It is anticipated to expand from $21.44 billion in 2025 to $23.5 billion by 2026, achieving a compound annual growth rate (CAGR) of 9.6%. This historical expansion can be attributed to factors like the reliance on manual toxicology testing methods, limited laboratory automation, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market size is anticipated to expand significantly in the coming years, with projections indicating it will reach $33.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is primarily driven by the development of AI-driven predictive toxicology tools, the integration of genomics and transcriptomics in screening, the expansion of contract research organizations (CROS), a rising demand for real-time drug monitoring systems, and the implementation of cloud-based, secure data management platforms. Furthermore, major trends throughout this period include the increasing adoption of high-throughput screening technologies, the integration of LIMS and laboratory information systems, the growing utilization of predictive and AI-powered toxicology platforms, the broadening scope of workplace drug screening programs, and an elevated emphasis on data security and compliance standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Drivers Are Affecting Demand In The Toxicology Drug Screening Market?

The escalating occurrence of drug abuse is anticipated to fuel the expansion of the toxicology drug screening market in the future. This refers to the detrimental or excessive consumption of drugs for reasons other than medical, adversely affecting an individual’s well-being and existence. The frequency of drug abuse is increasing, driven by heightened stress and difficulties with mental health, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or potential overdose. For example, data from August 2024, provided by the National Records of Scotland (NRS), a Scotland-based government department, revealed that Scotland documented 1,172 drug misuse deaths in 2023. This represented a 12% increase, or 121 additional deaths, when compared to the figures from 2022. Consequently, the growing incidence of drug abuse is propelling the toxicology drug screening market.

Which Segment Groups Are Influencing The Toxicology Drug Screening Market?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Trends Are Influencing The Development Of The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are focusing on introducing innovative solutions, such as the 3D liver microphysiological system, which enables the culturing of highly biomimetic human liver microtissues with organized cell arrangements and active metabolic function. The 3D liver microphysiological system (MPS) represents an advanced in vitro platform engineered to replicate the physiological microenvironment of the human liver with greater precision than traditional cell culture methods, typically involving the cultivation of multiple types of human liver cells. For instance, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in the development of organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit was developed for in vitro profiling of human drug-induced liver injury and incorporates a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it facilitates effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.

Who Are The Prominent Global Companies Shaping The Toxicology Drug Screening Market Landscape?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Toxicology Drug Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795